Survey of patient perception of pre-analytical requirements for blood testing in the UK and RoI.


Journal

Annals of clinical biochemistry
ISSN: 1758-1001
Titre abrégé: Ann Clin Biochem
Pays: England
ID NLM: 0324055

Informations de publication

Date de publication:
03 2021
Historique:
pubmed: 5 12 2020
medline: 7 7 2021
entrez: 4 12 2020
Statut: ppublish

Résumé

A patient survey developed by the Pre-Analytical Phase Special Interest Group of the Association for Clinical Biochemistry and Laboratory Medicine (ACB-PA-SIG) was conducted during November and December 2019. The survey aimed to determine the quality of information provided to patients in preparation for their blood test(s). In addition, the ACB-PA-SIG provide a number of recommendations, which, if adopted, may yield higher quality test results and improve patient management. The survey was distributed at phlebotomy suites in two Hospitals: Ipswich Hospital (United Kingdom [UK]), and Cork University Hospital (Republic of Ireland [RoI]). Overall, 235 survey responses were received from the two sites. A total of 103 respondents received no information about preparing for their blood test and 92 had been told they did not need to fast. None of the patients surveyed had been instructed to fast for 12 h. Twenty-two patients had been told to avoid certain foods, drinks or medication, 14 were told to avoid strenuous activity and 41 respondents had been informed of the need to avoid alcohol/smoking prior to their blood test. Overall, only approximately 78 felt well informed about the blood taking process. Based on the results of this survey, the ACB-PA-SIG conclude that: (1) clinicians should provide clear written information to patients regarding pre-analytical requirements; and (2) effective communication between laboratories and General Practitioners is required to disseminate information. In this paper, the ACB-PA-SIG provide a list of pre-analytical recommendations to standardize and improve practice across the UK and RoI.

Sections du résumé

BACKGROUND
A patient survey developed by the Pre-Analytical Phase Special Interest Group of the Association for Clinical Biochemistry and Laboratory Medicine (ACB-PA-SIG) was conducted during November and December 2019. The survey aimed to determine the quality of information provided to patients in preparation for their blood test(s). In addition, the ACB-PA-SIG provide a number of recommendations, which, if adopted, may yield higher quality test results and improve patient management.
METHODS
The survey was distributed at phlebotomy suites in two Hospitals: Ipswich Hospital (United Kingdom [UK]), and Cork University Hospital (Republic of Ireland [RoI]).
RESULTS
Overall, 235 survey responses were received from the two sites. A total of 103 respondents received no information about preparing for their blood test and 92 had been told they did not need to fast. None of the patients surveyed had been instructed to fast for 12 h. Twenty-two patients had been told to avoid certain foods, drinks or medication, 14 were told to avoid strenuous activity and 41 respondents had been informed of the need to avoid alcohol/smoking prior to their blood test. Overall, only approximately 78 felt well informed about the blood taking process.
CONCLUSIONS
Based on the results of this survey, the ACB-PA-SIG conclude that: (1) clinicians should provide clear written information to patients regarding pre-analytical requirements; and (2) effective communication between laboratories and General Practitioners is required to disseminate information. In this paper, the ACB-PA-SIG provide a list of pre-analytical recommendations to standardize and improve practice across the UK and RoI.

Identifiants

pubmed: 33275445
doi: 10.1177/0004563220982325
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

132-140

Auteurs

S Hepburn (S)

Department of Clinical Biochemistry, Ipswich Hospital, East Suffolk and North Essex NHS Foundation Trust, Ipswich, UK.
Association of Clinical Biochemistry and Laboratory Medicine Pre-Analytical Phase Special Interest Group, London, UK.

M Jankute (M)

Association of Clinical Biochemistry and Laboratory Medicine Pre-Analytical Phase Special Interest Group, London, UK.
Department of Clinical Chemistry, Birmingham Children's Hospital, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.

M P Cornes (MP)

Association of Clinical Biochemistry and Laboratory Medicine Pre-Analytical Phase Special Interest Group, London, UK.
Department of Clinical Chemistry, Worcestershire Acute Hospital NHS Trust, Worcester, UK.

N Rico Rios (NR)

Department of Clinical Biochemistry, Cork University Hospital, Wilton, Cork, Republic of Ireland.

A Stretton (A)

Association of Clinical Biochemistry and Laboratory Medicine Pre-Analytical Phase Special Interest Group, London, UK.
Becton, Dickinson U.K. Ltd, Wokingham, UK.

S J Costelloe (SJ)

Association of Clinical Biochemistry and Laboratory Medicine Pre-Analytical Phase Special Interest Group, London, UK.
Department of Clinical Biochemistry, Cork University Hospital, Wilton, Cork, Republic of Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH